Sciona and WellGen case study: adapting pharmaceutical technologies for the food industry

Publication Date	May 2007
Publisher	Datamonitor
Product Type	Report
Pages	7
ISBN Number	not applicable
Product Code	DAT05207

Buy this product or for assistance call +44 20 7060 7474

PDF £175.00$291 | €196

FAX Order above formats by FAX

Summary

Introduction

This report on Sciona and WellGen forms part of Datamonitor's case studies series, which explores business practices across a variety of disciplines and business sectors. Each case study provides a concise evaluation of a company that stands out in some area of its strategic operations.

Reasons to Purchase

Gain insight into the methods used by important industry players to give them a competitive edge
Identify specific areas for operational improvements
Capitalize on the knowledge of experienced companies when entering a new niche or market

Content

Catalyst
Summary
Analysis
- Sciona: developing a personalized approach to a consumer's diet
- Cellf Assessment Kits provide personalized genetic based nutrition advice
- Nutritional recommendations are automated using proprietary software
- UK product launch was withdrawn due to early criticisms
- US launch is deemed a success, leading to other possible country launches
- WellGen: investing in a novel approach to ingredient discovery
- WellGen uses transciptomics to search for new food ingredients
- The company's first product is an anti-inflammatory food additive
- The food industry has shown interest in WellGen's ingredient technology
Appendix
- Case study series
- Methodology
- Further reading
List Of Tables
- Table 1: Genetic variations screened by the Cellf Assessment Kit from Sciona, 2006
List Of Figures
- Figure 1: The Cellf Assessment Kit from Sciona
- Figure 2: Pro-inflammatory metabolic pathways